Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1 [Articles]

Elsby, R., Hare, V., Neal, H., Outteridge, S., Pearson, C., Plant, K., Gill, R. U., Butler, P., Riley, R. J.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
Published 2018